Mesenchymal Stem Cell Therapy for Osteoarthritis from Canada
Allogeneic mesenchymal stem cells (MSCs) derived from umbilical cord tissue, expanded and cryopreserved for intra-articular injection to reduce inflammation in knee osteoarthritis. Falls under HTS 3002.51.00.00 as cell therapy products due to their modified cell culture status for regenerative therapeutic purposes. These biologics promote cartilage repair via immunomodulatory effects.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Verify GMP-compliant manufacturing and donor screening certificates to meet FDA regenerative medicine standards
• Use dry shippers or liquid nitrogen dewars for transport; monitor temperature excursions with data loggers